Literature DB >> 10590905

Current concepts of cerebral malformation syndromes.

M H Lequin1, A J Barkovich.   

Abstract

In the past, children with many brain malformations were classified as having static encephalopathies (cerebral palsy), often attributed to perinatal or prenatal distress. Understanding of the frequency and clinical manifestations of brain malformations, however, has increased dramatically in the past 10 to 15 years. During this time, it has become apparent that many static encephalopathies in children have a brain malformation as their substrate. Most of the increase in our knowledge can be attributed to advances in neuroimaging and in molecular biology. In general, radiologic analysis of the brain allows similar malformations to be classified together. Subsequent genetic analysis of the affected children often reveals the affected gene, leading to identification of the gene product and, ideally, an ultimate understanding of the molecular mechanism of malformation. Currently, many genes involved in the complicated process of neuronal proliferation, migration, and organization are being identified. Knowledge of these genes and a better radiologic classification system enable the referring physician to give better care, more sophisticated genetic counseling, and a more precise prognosis for the child. To illustrate this mechanism of classification, three groups of malformations are discussed, in which a combination of neuroimaging analysis and molecular biologic analysis have led to a new understanding of the malformation syndromes.

Entities:  

Mesh:

Year:  1999        PMID: 10590905     DOI: 10.1097/00008480-199912000-00003

Source DB:  PubMed          Journal:  Curr Opin Pediatr        ISSN: 1040-8703            Impact factor:   2.856


  6 in total

1.  Epilepsy and Cortical Dysplasias.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  2000-11       Impact factor: 3.598

Review 2.  Mannitol-enhanced delivery of stem cells and their growth factors across the blood-brain barrier.

Authors:  Gabriel S Gonzales-Portillo; Paul R Sanberg; Max Franzblau; Chiara Gonzales-Portillo; Theo Diamandis; Meaghan Staples; Cyndy D Sanberg; Cesar V Borlongan
Journal:  Cell Transplant       Date:  2014-01-29       Impact factor: 4.064

3.  A diagnostic approach for cerebral palsy in the genomic era.

Authors:  Ryan W Lee; Andrea Poretti; Julie S Cohen; Eric Levey; Hilary Gwynn; Michael V Johnston; Alexander H Hoon; Ali Fatemi
Journal:  Neuromolecular Med       Date:  2014-10-04       Impact factor: 3.843

Review 4.  Permeating the blood brain barrier and abrogating the inflammation in stroke: implications for stroke therapy.

Authors:  Cesar V Borlongan; Loren E Glover; P R Sanberg; David C Hess
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

5.  Mannitol facilitates neurotrophic factor up-regulation and behavioural recovery in neonatal hypoxic-ischaemic rats with human umbilical cord blood grafts.

Authors:  T Yasuhara; K Hara; M Maki; L Xu; G Yu; M M Ali; T Masuda; S J Yu; E K Bae; T Hayashi; N Matsukawa; Y Kaneko; N Kuzmin-Nichols; S Ellovitch; E L Cruz; S K Klasko; C D Sanberg; P R Sanberg; C V Borlongan
Journal:  J Cell Mol Med       Date:  2010-04       Impact factor: 5.310

6.  Rethinking schizophrenia in the context of normal neurodevelopment.

Authors:  Vibeke S Catts; Samantha J Fung; Leonora E Long; Dipesh Joshi; Ans Vercammen; Katherine M Allen; Stu G Fillman; Debora A Rothmond; Duncan Sinclair; Yash Tiwari; Shan-Yuan Tsai; Thomas W Weickert; Cynthia Shannon Weickert
Journal:  Front Cell Neurosci       Date:  2013-05-15       Impact factor: 5.505

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.